Internal Medicine, Infectious Disease · Sellersville, PA
NPI
1770904724
Since 2013
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
817 Lawn Ave
Sellersville, PA, 18960
Phone (215) 257-8450
Groups this clinician bills Medicare through
Medicare paid, 2024
$246K
2,940 services
Medicare patients, 2024
682
Average age 78
Drug cost, 2024
$148K
357 prescriptions
Company payments, 2025
$105
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirish Jagga was code 99232 (hospital e&m - subsequent), 1,754 times for 475 patients. In total Shirish Jagga billed 2,940 services in 13 codes, and Medicare paid $246K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,754 | 475 | $62.65 | $110K |
| 99223 Hospital E&M - Initial | Facility | 443 | 383 | $137.75 | $61K |
| 99233 Hospital E&M - Subsequent | Facility | 403 | 227 | $94.96 | $38K |
| 99222 Hospital E&M - Initial | Facility | 210 | 200 | $105.08 | $22K |
| 99215 Office E&M - Established | Office | 31 | 28 | $119.20 | $3,695 |
| 99305 SNF E&M | Facility | 29 | 26 | $107.75 | $3,125 |
| 99214 Office E&M - Established | Office | 25 | 20 | $100.61 | $2,515 |
| 99306 SNF E&M | Facility | 20 | 20 | $145.96 | $2,919 |
By year: 2022 $392K for 5,070 services; 2023 $343K for 4,252 services; 2024 $246K for 2,940 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirish Jagga prescribed most often to Medicare patients was Vancomycin Hcl, with 57 prescriptions and refills. In total Shirish Jagga wrote 357 Medicare prescriptions that cost $148K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 57 | 57 | 15 | $14K |
| Ceftriaxone Ceftriaxone Sodium | 40 | 40 | Under 11 | $3,075 |
| Cefazolin Sodium Generic | 37 | 37 | Under 11 | $1,010 |
| Ampicillin Sodium Generic | 26 | 26 | Under 11 | $8,562 |
| Amoxicillin Generic | 25 | 25 | Under 11 | $381 |
| Doxycycline Hyclate Generic | 25 | 37 | Under 11 | $498 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 19 | 19 | Under 11 | $81K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 19 | Under 11 | $123 |
| Cefadroxil Generic | 12 | 12 | Under 11 | $147 |
| Ceftazidime Generic | 12 | 12 | Under 11 | $1,480 |
| Cefuroxime Cefuroxime Axetil | 11 | 11 | Under 11 | $569 |
Brand drugs: 31 claims; generic drugs: 326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirish Jagga $105 ($105 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $105.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.